Latest filing published 09 Sept 2026 for Bio-Rad Laboratories, INC..
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Roop Kalyan Lakkaraju discloses dealings in 4 companies, chiefly Benchmark Electronics Inc, Bio-Rad Laboratories, Inc. and Infinera Corp. In total, 48 filings cover trades dated from 13 May 2016 to 6 September 2026.
Purchases make up the whole of the open-market record (6 purchases, €107k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 26 share grants and 15 option exercises.
In size, the median ticket on the buying side is €12k. Clusters matter here: 4 out of 6 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 9 September 2026: an option exercise, in Bio-Rad Laboratories, Inc. The last insider purchase was made public on 5 August 2021, 1,905 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 27 declarations